Pablo Legorreta

Pablo Legorreta is the founder, CEO, and Chairman of Royalty Pharma plc. He has deployed over $20 billion for funding biopharmaceutical advancements and serves as a board member of ITB-MED. Pablo co-founded Pharmakon Advisors and ProKidney, LLC, and founded and chairs Alianza Médica para la Salud. He also serves on the boards of the New York Academy of Sciences and Rockefeller University. Prior to Royalty Pharma, he was an investment banker at Lazard Frères in Paris and New York. He has served on the board of the Zelarion Group since 2018.